11/21/2024

Janusmed fosterpåverkan

Janusmed fosterpåverkan – Lariam

Janusmed fosterpåverkan tillhandahåller bedömningar av eventuella risker för fostret, när en gravid kvinna använder olika läkemedel. Observera att texterna är generella, och att en bedömning måste göras i varje enskilt fall. Om du inte är medicinskt utbildad, läs först vår information för patienter och allmänhet.

För att komma till startsidan för Janusmed fosterpåverkan och för att göra sökningar klicka här.

Tillbaka till index
2 2
2 2

Meflokin

Meflokin

Klass : 2

Visa all info

Skriv ut

Kontakta oss

  1. Phillips-Howard PA, Wood D. The safety of antimalarial drugs in pregnancy. Drug Saf. 1996;14:131-45.

  2. Phillips-Howard PA, Steffen R, Kerr L, Vanhauwere R, Schildknecht J, Fuchs E et al. Safety of mefloquine and other antimalarial agents in first trimester of pregnancy. J Travel Med 1998;5:121-6.

  3. González R, Desai M, Macete E, Ouma P, Kakolwa MA, Abdulla S et al. Intermittent preventive treatment of malaria in pregnancy with mefloquine in HIV-infected women receiving cotrimoxazole prophylaxis: a multicenter randomized placebo-controlled trial. PLoS Med. 2014;11:e1001735.

  4. Briggs G, Towers CV, Forinash AB. Drugs in pregnancy and lactation: A reference guide to fetal and neonatal risk. 12th ed; 2021.

  5. González R, Pons-Duran C, Piqueras M, Aponte JJ, Ter Kuile FO, Menéndez C. Mefloquine for preventing malaria in pregnant women. Cochrane Database Syst Rev. 2018;11(11):CD011444.

  6. González R, Hellgren U, Greenwood B, Menéndez C. Mefloquine safety and tolerability in pregnancy: a systematic literature review. Malar J. 2014;13(75):75.

  7. Nosten F, Vincenti M, Simpson J, Yei P, Thwai KL, de Vries A et al. The effects of mefloquine treatment in pregnancy. Clin Infect Dis 1999;28:808-15.

  8. Schlagenhauf P, Blumentals WA, Suter P, Regep L, Vital-Durand G, Schaerer MT et al. Pregnancy and fetal outcomes after exposure to mefloquine in the pre- and periconception period and during pregnancy. Clin Infect Dis. 2012;54:e124-31.

  9. McGready R, Brockman A, Cho T, Cho D, van Vugt M, Luxemburger C et al. Randomized comparison of mefloquine-artesunate versus quinine in the treatment of multidrug-resistant falciparum malaria in pregnancy. Trans R Soc Trop Med Hyg. 2004;94:689-93.

  10. Nosten F, ter Kuile F, Maelankiri L, Chongsuphajaisiddhi T, Nopdonrattakoon L, Tangkitchot S et al. Mefloquine prophylaxis prevents malaria during pregnancy: a double-blind, placebo-controlled study. J Infect Dis. 1994;169:595-603.

  11. Briand V, Bottero J, Noël H, Masse V, Cordel H, Guerra J et al. Intermittent treatment for the prevention of malaria during pregnancy in Benin: a randomized, open-label equivalence trial comparing sulfadoxine-pyrimethamine with mefloquine. J Infect Dis. 2009;200:991-1001.

  1. Phillips-Howard PA, Wood D. The safety of antimalarial drugs in pregnancy. Drug Saf. 1996;14:131-45.
  2. Phillips-Howard PA, Steffen R, Kerr L, Vanhauwere R, Schildknecht J, Fuchs E et al. Safety of mefloquine and other antimalarial agents in first trimester of pregnancy. J Travel Med 1998;5:121-6.
  3. González R, Desai M, Macete E, Ouma P, Kakolwa MA, Abdulla S et al. Intermittent preventive treatment of malaria in pregnancy with mefloquine in HIV-infected women receiving cotrimoxazole prophylaxis: a multicenter randomized placebo-controlled trial. PLoS Med. 2014;11:e1001735.
  4. Briggs G, Towers CV, Forinash AB. Drugs in pregnancy and lactation: A reference guide to fetal and neonatal risk. 12th ed; 2021.
  5. González R, Pons-Duran C, Piqueras M, Aponte JJ, Ter Kuile FO, Menéndez C. Mefloquine for preventing malaria in pregnant women. Cochrane Database Syst Rev. 2018;11(11):CD011444.
  6. González R, Hellgren U, Greenwood B, Menéndez C. Mefloquine safety and tolerability in pregnancy: a systematic literature review. Malar J. 2014;13(75):75.
  7. Nosten F, Vincenti M, Simpson J, Yei P, Thwai KL, de Vries A et al. The effects of mefloquine treatment in pregnancy. Clin Infect Dis 1999;28:808-15.
  8. Schlagenhauf P, Blumentals WA, Suter P, Regep L, Vital-Durand G, Schaerer MT et al. Pregnancy and fetal outcomes after exposure to mefloquine in the pre- and periconception period and during pregnancy. Clin Infect Dis. 2012;54:e124-31.
  9. McGready R, Brockman A, Cho T, Cho D, van Vugt M, Luxemburger C et al. Randomized comparison of mefloquine-artesunate versus quinine in the treatment of multidrug-resistant falciparum malaria in pregnancy. Trans R Soc Trop Med Hyg. 2004;94:689-93.
  10. Nosten F, ter Kuile F, Maelankiri L, Chongsuphajaisiddhi T, Nopdonrattakoon L, Tangkitchot S et al. Mefloquine prophylaxis prevents malaria during pregnancy: a double-blind, placebo-controlled study. J Infect Dis. 1994;169:595-603.
  11. Briand V, Bottero J, Noël H, Masse V, Cordel H, Guerra J et al. Intermittent treatment for the prevention of malaria during pregnancy in Benin: a randomized, open-label equivalence trial comparing sulfadoxine-pyrimethamine with mefloquine. J Infect Dis. 2009;200:991-1001.